Due Diligence and Art

Due Diligence and Art

Share this post

Due Diligence and Art
Due Diligence and Art
Mainstream pharma press admits that CRISPR technology failed.
mRNA, Gene Therapies and Biomanufacturing Fraud

Mainstream pharma press admits that CRISPR technology failed.

Moments of honesty from the least expected places should be cherished.

Sasha Latypova's avatar
Sasha Latypova
Mar 28, 2025
∙ Paid
320

Share this post

Due Diligence and Art
Due Diligence and Art
Mainstream pharma press admits that CRISPR technology failed.
118
62
Share

If you stand on a river bank and wait for failed gene therapies to float by… you will be flooded! Admission of failure from the pharma propaganda outlets, on the other hand, is a rare event. This washed up in my inbox recently:

“Exclusive: CRISPR delivery startup, based on UC Berkeley and UCSF science, shuts down.”

Due Diligence and Art is a reader-supp…

Keep reading with a 7-day free trial

Subscribe to Due Diligence and Art to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Sasha Latypova
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share